You Position: Home > Paper

Simvastatin inhibits the expressions of MCP-1 and ICAM-1 in mesangial cells by repressing the signal passageway of P38 MAPK

( views:225, downloads:20 )
Author:
No author available
Journal Title:
CHINESE JOURNAL OF DIABETES
Issue:
6
DOI:
10.3321/j.issn:1006-6187.2008.06.011
Key Word:
P38促分裂原活化蛋白激酶;单核细胞趋化蛋白;细胞间黏附因子;辛伐他汀; P38 mitogen-activated protein kinase;Monocyte chemoattractant protein; Intercellular adhesion molecule; Simvastatin

Abstract: Objective To explore the effect of P38 mitogen-activated protein kinase(P38MAPK)on diabetic nephropathy(DN)and the mechanism of simvastatin-prevented development of DN.Methods Rat mesangial cells(RMC)were incubated with high glucose(HG),advanced glycosylation end products(AGE)or H2O2 with or without pre-treatment with SB203580(P38MAPK specific inhibitor)or simvastatin(SI).The expressions of pho-P38MAPK,monocyte chemoattractant protein-1(MCP-1)and intercellular adhesion molecule-1(ICAM-1)in MC were detected by Western-blot or RT-PCR.Results HG,AGE or H2O2 were able to activate P38MAPK and increase the expressions of MCP-1 and ICAM-1 in RMC.The expressions of MCP-1 and ICAM-1 were inhibited by SB203580.SI inhibited the activation of P38MAPK and reduced the expressions of MCP-1 and ICAM-1.Conclusions P38MAPK is an upstream signaling molecule of MCP-1 and ICAM-1.P38MAPK may be one of the initiating signals of DN.SI can inhibit the expressions of MCP-1 and ICAM-1 by repressing P38MAPK signaling pathway and therefore prevent the development of DN

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn